Figure 7
From: Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury
Losartan attenuates pro-fibrotic genes in kidney after AKI.
QPCR of renal pro-fibrotic genes (a) transforming growth factor-b1 (Tgfb1), (b) Acta2, (c) Col1a1, and (d) Col3a1 at 5 months. N = 32 (NX), 27 (NX+IRI), 37 (Losartan) and 33 (Hydralazine) as shown in Fig. 5e. *P < 0.05, †P < 0.01, ‡P < 0.001.
